Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica and Valence. “Recursion has pioneered the massive, parallel generation of […]

What is the purpose of story-telling?

I was very pleased to receive, on a recent occasion [that accidentally happened to be my birthday!] a document sent to me by email, that told me (in so many words) that someone had been so inspired, or impressed, with my use of such devices as folk tal…